Target intelligence / Profile preview

Potassium two pore domain channel subfamily K member 9 (KCNK9)

Target
KCNK9
Molecular classification
Ion channel, Two pore (K2P) domain potassium channel
01

Overview

Potassium two pore domain channel subfamily K member 9 (KCNK9, also known as TASK3) is a pH-sensitive, two-pore domain potassium ion channel that contributes to “leak” potassium currents, helping to set membrane potential and regulate cellular excitability, especially in neurons. It is expressed most highly in the brain (notably cerebellum and hippocampus) but is present in various tissues including the adrenal gland and retina. KCNK9 is regulated by extracellular pH and signaling pathways involving G protein-coupled receptors, and is inhibited by various endogenous and pharmacologic molecules. Overexpression or amplification of KCNK9 has been identified in multiple human cancers, where it promotes proliferation and resistance to apoptosis, illustrating both physiological and pathological roles. Genetic variants of KCNK9 cause congenital imprinting syndromes. There are currently no approved drugs that specifically target KCNK9 clinically, but its modulation is a subject of active research for both neurologic and oncologic indications

Other names
TASK3TASK-3K2p9.1TWIK-related acid-sensitive K(+) channel 3Acid-sensitive potassium channel protein TASK-3Potassium channel subfamily K member 9Potassium channel, two pore domain subfamily K, member 9Two pore potassium channel KT3.2BIBARSTASK32KT3.2
02

Mechanism of action

Opening or closing the channel regulates potassium (K+) outflow, affecting membrane potential and cell excitability. Inhibition results in depolarization, altering neuronal signaling, hormone release, and potentially promoting or inhibiting tumorigenic processes. In oncogenesis, overexpression increases resistance to apoptosis and cell proliferation via alteration of membrane potential and downstream signaling pathways.

03

Biological functions

Maintenance of resting membrane potentialRegulation of neuronal excitabilityCellular response to pH changes (pH-dependent gating)Regulation of aldosterone secretionContribution to action potential repolarization and hyperpolarizationInhibition of apoptosisSupport of high-frequency neuronal firingRegulation of respiration through serotonergic neuron activityModulation of synaptic transmission in the retina
04

Disease associations

Cancer (notably breast, lung, colon, prostate carcinomas)Birk-Barel syndrome (imprinting disorder)Kcnk9 imprinting syndromeNeurologic/Neuropsychiatric syndromes (e.g., cognitive deficits, increased appetite, obesity in knockout mice)
05

Safety considerations

Targeting KCNK9/TASK3 could impact CNS function, particularly cerebellar and hippocampal activity, with potential for neurologic side effects (cognitive effects, altered arousal, etc.)Potential dysregulation in respiratory or cardiovascular physiology if used systemicallyImprinting and parent-of-origin expression effects may complicate targeting in the brainMouse knockout phenotypes suggest risk for altered motor control, increased appetite/obesity, and cognitive disruption
06

Interacting drugs

Volatile anesthetics (e.g., halothane, isoflurane)

4 more in the full profile.

07

Biomarkers

KCNK9/TASK3 overexpression in tumor tissue may serve as a biomarker for certain carcinomas (e.g., breast, colon, lung, prostate)Mutational analysis (G95E mutation as functional marker in research)No clinically established prognostic or predictive biomarker use at present

Beyond the preview

Go deeper on Potassium two pore domain channel subfamily K member 9 (KCNK9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium two pore domain channel subfamily K member 9 (KCNK9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call